1. Einhäupl, K, Stam, J, Bousser, M-G, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010; 17: 1229–1235. DOI: 10.1111/j.1468-1331.2010.03011.x.
Google Scholar | Crossref | Medline | ISI2. Ferro, JM, Bousser, M-G, Canhão, P, for the European Stroke Organisation, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J 2017; 2: 195–221. DOI: 10.1177/2396987317719364.
Google Scholar | SAGE Journals | ISI3. Idiculla, PS, Gurala, D, Palanisamy, M, et al. Cerebral venous thrombosis: a comprehensive review. Eur Neurol 2020; 83: 369–379. DOI: 10.1159/000509802.
Google Scholar | Crossref | Medline4. Behrouzi, R, Punter, M. Diagnosis and management of cerebral venous thrombosis. Clin Med 2018; 18: 75–79. DOI: 10.7861/clinmedicine.18-1-75.
Google Scholar | Crossref | Medline5. Ropper, AH, Klein, JP. Cerebral venous thrombosis. New Engl J Med 2021; 385: 59–64. DOI: 10.1056/NEJMra2106545.
Google Scholar | Crossref | Medline6. Ferro, JM, Canhão, P, Stam, J, et al. Prognosis of cerebral vein and dural sinus thrombosis results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664–670. DOI: 10.1161/01.STR.0000117571.76197.26.
Google Scholar | Crossref | Medline | ISI7. Martinelli, I, Battaglioli, T, Pedotti, P, et al. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003; 102: 1363–1366. DOI: 10.1182/blood-2003-02-0443.
Google Scholar | Crossref | Medline | ISI8. Morris, AAM, Kožich, V, Santra, S, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis 2016; 40: 49–74. DOI: 10.1007/s10545-016-9979-0
Google Scholar | Crossref | Medline9. Mudd, SH, Skovby, F, Levy, HL, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985; 37: 1–31.
Google Scholar | Medline | ISI10. Sellos-Moura, M, Glavin, F, Lapidus, D, et al. Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison. BMC Health Serv Res 2020; 20: 183. DOI: 10.1186/s12913-020-5054-5.
Google Scholar | Crossref | Medline11. Sacharow, SJ, Picker, JD, Levy, HL. Homocystinuria caused by Cystathionine Beta-Synthase Deficiency. In GeneReviews® [Internet]. Updated 18 May 18 2017, https://www.ncbi.nlm.nih.gov/books/NBK1524/ (2004, Accessed 7 June 2021).
Google Scholar12. Woods, E, Dawson, C, Senthil, L, et al. Cerebral venous thrombosis as the first presentation of classical homocystinuria in an adult patient. BMJ Case Rep 2017; 2017.
Google Scholar13. Eslamiyeh, H, Ashrafzadeh, F, Akhondian, J, et al. Homocystinuria: a rare disorder presenting as cerebral sinovenous thrombosis. Iranian J Child Neurol 2015; 9: 53–57.
Google Scholar | Medline14. Camargo, EC, Huang, SY, PhD, et al. Case 7-2018: a 25-year-old man with new-onset seizures. New Engl J Med 2018; 378: 941–948.
Google Scholar | Crossref | Medline15. Asamoah, A, Wei, S, Jackson, KE, et al. Diagnosis of classic homocystinuria in two boys presenting with acute cerebral venous thrombosis and neurologic dysfunction after normal newborn screening. Int J Neonatal Screen 2021; 7: 48. DOI: 10.3390/ijns7030048.
Google Scholar | Crossref | Medline16. Lentz, SR Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemos 2005; 3: 1646–1654. DOI: 10.1111/j.1538-7836.2005.01364.xt
Google Scholar | Crossref | Medline | ISI17. Saposnik, G, Barinagarrementeria, F, Brown, RD, et al. Diagnosis and management of cerebral venous thrombosis a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 1158–1192. DOI: 10.1161/STR.0b013e31820a8364.
Google Scholar | Crossref | Medline | ISI18. Cantu, C, Alonso, E, Jara, A, et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004; 35: 1790–1794. DOI: 10.1161/01.STR.0000132570.24618.78.
Google Scholar | Crossref | Medline | ISI19. Ray, JG . Meta-analysis of Hyperhomocysteinemia as a Risk Factor for Venous Thromboembolic Disease. Arch Intern Med 1998; 158: 2101–2106. DOI: 10.1001/archinte.158.19.2101.
Google Scholar | Crossref | Medline20. den Heijer, M, Rosendaal, FR, Blom, HJ, et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998; 80: 874–877.
Google Scholar | Crossref | Medline | ISI21. Alvis-Miranda, HH, Castellar-Leones, SM, Alcala-Cerra, G, et al. Cerebral sinus venous thrombosis. J Neurosci Rural Pract 2013; 04: 427–438. DOI: 10.4103/0976-3147.120236.
Google Scholar | Crossref22. Zschocke, J, Hoffmann, GF. Vademecum metabolicum diagnosis and treatment of inborn errors of metabolism. 5th ed. Germany: Thieme Publishing Group, 2021.
Google Scholar23. Boushey, CJ, Beresford, SAA, Omenn, GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049–1057. DOI: 10.1001/jama.1995.03530130055028.
Google Scholar | Crossref | Medline | ISI